4.4 Article

The unremarkable alveolar epithelial glycocalyx: a thorium dioxide-based electron microscopic comparison after heparinase or pneumolysin treatment

期刊

HISTOCHEMISTRY AND CELL BIOLOGY
卷 160, 期 2, 页码 83-96

出版社

SPRINGER
DOI: 10.1007/s00418-023-02211-7

关键词

Alveolar epithelial glycocalyx; Thorium dioxide; Heparinase; Pneumolysin; Electron tomography; Lung stereology

向作者/读者索取更多资源

Recent investigations have focused on the properties of glycocalyx in endothelial cells, while there is limited research on this complex structure in alveolar epithelial cells. In this study, the alveolar glycocalyx ultrastructure was characterized using transmission electron microscopy in human lung tissue and mouse lungs. The results demonstrate a reduction in glycocalyx components and density in response to treatment with heparinase or pneumolysin. This research provides quantitative data on the distribution of glycocalyx in alveolar epithelial cells and highlights the structural changes caused by glycocalyx shedding.
Recent investigations analyzed in depth the biochemical and biophysical properties of the endothelial glycocalyx. In comparison, this complex cell-covering structure is largely understudied in alveolar epithelial cells. To better characterize the alveolar glycocalyx ultrastructure, unaffected versus injured human lung tissue explants and mouse lungs were analyzed by transmission electron microscopy. Lung tissue was treated with either heparinase (HEP), known to shed glycocalyx components, or pneumolysin (PLY), the exotoxin of Streptococcus pneumoniae not investigated for structural glycocalyx effects so far. Cationic colloidal thorium dioxide (cThO(2)) particles were used for glycocalyx glycosaminoglycan visualization. The level of cThO(2) particles orthogonal to apical cell membranes ( estimates stained glycosaminoglycan height) of alveolar epithelial type I (AEI) and type II (AEII) cells was stereologically measured. In addition, cThO(2) particle density was studied by dual-axis electron tomography ( estimates stained glycosaminoglycan density in three dimensions). For untreated samples, the average cThO(2) particle level was & AP; 18 nm for human AEI, & AP; 17 nm for mouse AEI, & AP; 44 nm for human AEII and & AP; 35 nm for mouse AEII. Both treatments, HEP and PLY, resulted in a significant reduction of cThO(2) particle levels on human and mouse AEI and AEII. Moreover, a HEP- and PLY-associated reduction in cThO(2) particle density was observed. The present study provides quantitative data on the differential glycocalyx distribution on AEI and AEII based on cThO(2) and demonstrates alveolar glycocalyx shedding in response to HEP or PLY resulting in a structural reduction in both glycosaminoglycan height and density. Future studies should elucidate the underlying alveolar epithelial cell type-specific distribution of glycocalyx subcomponents for better functional understanding.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据